Data as of Apr 17
| +0.54 / +1.71%|
The 5 analysts offering 12-month price forecasts for Medifast Inc have a median target of 31.97, with a high estimate of 37.00 and a low estimate of 27.00. The median estimate represents a -0.28% decrease from the last price of 32.06.
The current consensus among 5 polled investment analysts is to Buy stock in Medifast Inc. This rating has held steady since April, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.